MW

Mohmmad Younus Wani

Also known as: M.Y.Wani, Wani, M.Y

University of Jeddah, The University of Texas Health Science Center at Houston, Jamia Millia Islamia, University of Coimbra

Research areas: Chemistry · Organic Chemistry · Antifungal resistance and susceptibility · Metal complexes synthesis and properties · Synthesis and biological activity

ORCID iD 0000-0002-1838-1337

About

Dr. Wani is an accomplished Associate Professor of Organic and Medicinal Chemistry, with extensive expertise in medicinal chemistry and drug discovery. His research spans peptide chemistry, linker technology, and the design of novel small molecule inhibitors. He honed his skills through postdoctoral training at the McGovern Medical School, Texas Medical Center, UTHealth, Houston, USA, and as an FCT Postdoctoral Fellow at the University of Coimbra, Portugal, gaining international experience in cutting-edge therapeutic development. Dr. Wani’s work bridges Chemistry, Biology and Artificial Intelligence (AI) driving innovative solutions to tackle complex biomedical challenges.

Employment

Education

Projects & Funding

  • Next-Generation Antimicrobial Peptides: Tackling Biofilm-Associated Multidrug Resistance in Infectious Diseases Saudi National Institute of Health
    2025 - 2028
  • Nano-coatings for Biofilm Eradication in Wound Management and Biomedical Applications University of Jeddah
    2024 - 2026
  •  Targeting Apoptosis in Candida auris with Novel Triazole Derivatives: Implications for Antifungal Therapy DSR, University of Jeddah
    2023 - 2024
  •  Induction of apoptosis and antioxidant adaptation by citral and its derivatives in azole-resistant C. albicans Deanship of Scientific Research, University of Jeddah
    2020 - 2021
  • Synthesis, antifungal evaluation and synergistic studies of cinnamaldehyde derivatives with Fluconazole Deanship of Scientific Research, University of Jeddah.
    2018 - Present
  •  Multicomponent synthesis of substituted amino tetrazoles derivatives Deanship of Scientific Research, University of Jeddah.
    2018 - Present
  • Apoptosis and pathogenicity modulations in Candida albicans by Eugenol-tosylate and its Congeners South African Medical Research Council
    2016 - Present
  • IUPAC World congress-Young scientist travel award IUPAC World congress
    2015 - Present
  • Development of Fungal Cell wall Targeted Anti-fungal Therapeutic Agents Fundo Regional para a Ciência e Tecnologia
    2013 - 2016
  • Systematic Exploration of Novel EhTrR Targeting Azole based Antiamoebic Lead Compounds Council of Scientific and Industrial Research
    2012 - 2013
  • International Young Chemists Conference Sandia National Laboratories
    2012 - Present
  • 4th EuCheMS Chemistry Congress EuCheMS
    2012 - Present

Publications (88)